Jinyu Bio-Technology Hits Day High with Strong 3.65% Intraday Surge

Jinyu Bio-Technology Co., Ltd. has experienced a notable increase of 3.65% on March 24, 2026, reaching an intraday high of CNY 13.72. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.78% on the same day. Despite the recent uptick, Jinyu's performance over the past week has seen a decline of 9.68%, and a more significant drop of 14.61% over the past month. However, the company has shown impressive resilience over the past year, boasting a remarkable return of 87.35%, significantly outperforming the China Shanghai Composite's 15.17% gain. Jinyu operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 17,377 million. The company has faced challenges in profitability, reflected in its low Return on Capital Employed (ROCE) of 6.64% and a declining trend in net sales and operating profit over the last five years. Despite these hurdles, Jinyu's stock has generated a substantial return over the past year, indicating a complex financial landscape for the company.